Literature DB >> 22884909

Characterization of inflammatory gene expression and galectin-3 function after spinal cord injury in mice.

Ahdeah Pajoohesh-Ganji1, Susan M Knoblach, Alan I Faden, Kimberly R Byrnes.   

Abstract

Inflammation has long been implicated in secondary tissue damage after spinal cord injury (SCI). Our previous studies of inflammatory gene expression in rats after SCI revealed two temporally correlated clusters: the first was expressed early after injury and the second was up-regulated later, with peak expression at 1-2 weeks and persistent up-regulation through 6 months. To further address the role of inflammation after SCI, we examined inflammatory genes in a second species, mice, through 28 days after SCI. Using anchor gene clustering analysis, we found similar expression patterns for both the acute and chronic gene clusters previously identified after rat SCI. The acute group returned to normal expression levels by 7 days post injury. The chronic group, which included C1qB, p22(phox) and galectin-3, showed peak expression at 7 days and remained up-regulated through 28 days. Immunohistochemistry and western blot analysis showed that the protein expression of these genes was consistent with the mRNA expression. Further exploration of the role of one of these genes, galectin-3, suggests that galectin-3 may contribute to secondary injury. In summary, our findings extend our prior gene profiling data by demonstrating the chronic expression of a cluster of microglial associated inflammatory genes after SCI in mice. Moreover, by demonstrating that inhibition of one such factor improves recovery, the findings suggest that such chronic up-regulation of inflammatory processes may contribute to secondary tissue damage after SCI, and that there may be a broader therapeutic window for neuroprotection than generally accepted. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22884909      PMCID: PMC3433585          DOI: 10.1016/j.brainres.2012.07.058

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  43 in total

1.  Expression of two temporally distinct microglia-related gene clusters after spinal cord injury.

Authors:  Kimberly R Byrnes; Jorge Garay; Simone Di Giovanni; Andrea De Biase; Susan M Knoblach; Eric P Hoffman; Vilen Movsesyan; Alan I Faden
Journal:  Glia       Date:  2006-03       Impact factor: 7.452

2.  Gene expression profiling of cathepsin D, metallothioneins-1 and -2, osteopontin, and tenascin-C in a mouse spinal cord injury model by cDNA microarray analysis.

Authors:  Masayuki Hashimoto; Masao Koda; Hidetoshi Ino; Katsunori Yoshinaga; Atsushi Murata; Masashi Yamazaki; Kensuke Kojima; Kan Chiba; Chisato Mori; Hideshige Moriya
Journal:  Acta Neuropathol       Date:  2004-12-09       Impact factor: 17.088

3.  Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains.

Authors:  D Michele Basso; Lesley C Fisher; Aileen J Anderson; Lyn B Jakeman; Dana M McTigue; Phillip G Popovich
Journal:  J Neurotrauma       Date:  2006-05       Impact factor: 5.269

4.  Suppression of endotoxin-induced proinflammatory responses by citrus pectin through blocking LPS signaling pathways.

Authors:  Chien-Ho Chen; Ming-Thau Sheu; Tzeng-Fu Chen; Ying-Ching Wang; Wen-Chi Hou; Der-Zen Liu; Tsao-Chuen Chung; Yu-Chih Liang
Journal:  Biochem Pharmacol       Date:  2006-08-22       Impact factor: 5.858

5.  Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma.

Authors:  M T Fitch; C Doller; C K Combs; G E Landreth; J Silver
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

6.  Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways.

Authors:  Gabriela C Fernández; Juan M Ilarregui; Carolina J Rubel; Marta A Toscano; Sonia A Gómez; Macarena Beigier Bompadre; Martín A Isturiz; Gabriel A Rabinovich; Marina S Palermo
Journal:  Glycobiology       Date:  2004-12-15       Impact factor: 4.313

7.  Neuronal plasticity after spinal cord injury: identification of a gene cluster driving neurite outgrowth.

Authors:  Simone Di Giovanni; Alan I Faden; Alexander Yakovlev; Jonathan S Duke-Cohan; Tom Finn; Melissa Thouin; Susan Knoblach; Andrea De Biase; Barbara S Bregman; Eric P Hoffman
Journal:  FASEB J       Date:  2004-11-02       Impact factor: 5.191

8.  The cellular inflammatory response in human spinal cords after injury.

Authors:  Jennifer C Fleming; Michael D Norenberg; David A Ramsay; Gregory A Dekaban; Alexander E Marcillo; Alvaro D Saenz; Melissa Pasquale-Styles; W Dalton Dietrich; Lynne C Weaver
Journal:  Brain       Date:  2006-10-28       Impact factor: 13.501

9.  Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages.

Authors:  F T Liu; D K Hsu; R I Zuberi; I Kuwabara; E Y Chi; W R Henderson
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

10.  Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain.

Authors:  Mélanie Lalancette-Hébert; Geneviève Gowing; Alain Simard; Yuan Cheng Weng; Jasna Kriz
Journal:  J Neurosci       Date:  2007-03-07       Impact factor: 6.167

View more
  23 in total

1.  Pharmacological inhibition of spinal cord injury-stimulated ribosomal biogenesis does not affect locomotor outcome.

Authors:  Ewa Kilanczyk; Kariena R Andres; Justin Hallgren; Sujata Saraswat Ohri; Marikki Laiho; Scott R Whittemore; Michal Hetman
Journal:  Neurosci Lett       Date:  2017-02-07       Impact factor: 3.046

2.  Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury.

Authors:  Ahdeah Pajoohesh-Ganji; Mark P Burns; Sonali Pal-Ghosh; Gauri Tadvalkar; Nicole G Hokenbury; Mary Ann Stepp; Alan I Faden
Journal:  Brain Res       Date:  2014-03-11       Impact factor: 3.252

3.  Evaluation of medicated gel as a supplement to providing acetaminophen in the drinking water of C57BL/6 mice after surgery.

Authors:  Amanda C Christy; Kimberly R Byrnes; Timothy L Settle
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-03       Impact factor: 1.232

4.  Characterization of the expression and inflammatory activity of NADPH oxidase after spinal cord injury.

Authors:  S J Cooney; Y Zhao; K R Byrnes
Journal:  Free Radic Res       Date:  2014-06-19

5.  NADPH oxidase isoform expression is temporally regulated and may contribute to microglial/macrophage polarization after spinal cord injury.

Authors:  Sara Bermudez; Guzal Khayrullina; Yujia Zhao; Kimberly R Byrnes
Journal:  Mol Cell Neurosci       Date:  2016-10-10       Impact factor: 4.314

6.  Late exercise reduces neuroinflammation and cognitive dysfunction after traumatic brain injury.

Authors:  Chun-Shu Piao; Bogdan A Stoica; Junfang Wu; Boris Sabirzhanov; Zaorui Zhao; Rainier Cabatbat; David J Loane; Alan I Faden
Journal:  Neurobiol Dis       Date:  2013-01-08       Impact factor: 5.996

7.  Inhibition of NOX2 reduces locomotor impairment, inflammation, and oxidative stress after spinal cord injury.

Authors:  Guzal Khayrullina; Sara Bermudez; Kimberly R Byrnes
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

8.  Evaluation of serum galectin-3 levels at Alzheimer patients by stages: a preliminary report.

Authors:  Tamer Yazar; Hülya Olgun Yazar; Murat Cihan
Journal:  Acta Neurol Belg       Date:  2020-08-27       Impact factor: 2.396

9.  Molecular and cellular changes in the lumbar spinal cord following thoracic injury: regulation by treadmill locomotor training.

Authors:  Hae Young Shin; Hyosil Kim; Min Jung Kwon; Dong Hoon Hwang; KiYoung Lee; Byung Gon Kim
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

10.  Cellular and temporal expression of NADPH oxidase (NOX) isotypes after brain injury.

Authors:  Sean J Cooney; Sara L Bermudez-Sabogal; Kimberly R Byrnes
Journal:  J Neuroinflammation       Date:  2013-12-17       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.